Anti-reflux therapy

Indian Pediatrics

Volumn 34, Issue 4, 1997, Pages 303-312

  Sandhu, Bhupinder K ^a  

^a BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CIMETIDINE; CISAPRIDE; DOMPERIDONE; GAVISCON; HISTAMINE H2 RECEPTOR ANTAGONIST; METOCLOPRAMIDE; OMEPRAZOLE; PROKINETIC AGENT; PROTON PUMP INHIBITOR; RANITIDINE; SUCRALFATE;

GASTROESOPHAGEAL REFLUX; HUMAN; REVIEW;

CHILD; ESOPHAGITIS; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HUMANS; INFANT; POSTURE; VOMITING;

EID: 0030923692     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Carre IJ. Clinical significance of gastroesophageal reflux. Arch Dis Child 1984; 59: 911-912.
2. Booth IW. Silent gastroesophageal reflux: How much do we miss? Arch Dis Child 1992; 67: 1325-1327.
3. Abrahams P, Burkitt BFE. Hiatus hernia and gastroesophageal reflux in children and adolescents with cerebral palsy. Austr Pediatr J 1980; 6: 41-46.
4. Sandheimer JM, Morris BA. Gastroesophageal reflux among severely retarded children. J Pediatr 1979; 97: 710-714.
5. Puntis JWL, Smith HL, Buick RG, Booth IW. Effects of dystonic movement on esophageal peristalsis in Sandifer's syndrome. Arch Dis Child 1989; 64: 1311-1313.
6. Boix-Ochoa J, Lafuenta JM, Gil-Vernet JM. Twenty-four hour esophageal pH monitoring in gastroesophageal reflux. J Pediatr Surg 1980; 15: 74-78.
7. Vandenplas Y, Sacre-Smits L. Continuous 24 hour esophageal pH monitoring in 285 asymptomatic infants 0-15 months old. J Pediatr Gastroenterol Nutr 1987; 6: 220-224.
8. Tappin DM, King C, Paten JY. Lower esophageal pH monitoring-A useful clinical tool. Arch Dis Child 1992; 67: 146-148.
9. Vandenplas Y, Belli D, Boige N, Bouquet J, Cadranel S, Cezrd JP, et al. A standardized protocol for the methodology of esophageal pH monitoring and interpretation of the data for the diagnosis of gastroesophageal reflux. ESPGAN Society Statement. J Pediatr Gastroenterol Nutr 1992; 14: 467-471.
10. Sandhu BK, Surendra Kumar D, Martin PB. Methods of evaluation of gastroesophageal reflux in children. In: Le Me' dicaments du Reflux Gastro-esophagian et de L' infection a Helicobacter pylori chez E' Enfant. Eds. Pons G, Dupont C. Berlin Springer-Verlag 1996; pp 11-17.
11. Fisher RS, Malmud IS. Esophageal scintigraphy: Are there advantages. Gastroenterology 1981; 80: 1066-1067.
12. Collins PJ, Houghton LA, Read NW, Horowitz M, Chatterton BE, Heddle R, et al. Role of proximal and distal stomach in mixed solid and liquid meal emptying. Gut 1991; 32: 615-619.
13. Holt S, Cervantes J, Wilkinson A, Wallace JHK. Measurement of gastric emptying rate in humans by real-time ultrasound. Gastroenterology 1986; 90: 918-923.
14. Vantrappen G. Methods to study gastric emptying. Dig Dis Sci 1994; 39 (Suppl): 915-945.
15. Vandenplas Y, Ashkenazi A, Belli D, Boige N, Bouquet J, Cadranel S, et al. A proposition for the diagnosis and treatment of gastro-esophageal reflux disease in children. Eur J Pediatr 1993; 152: 704-711.
16. Orestein SR, Whittington PF, Orensteim DM. The infant seat as a treatment for gastro-esophageal reflux. N Engl J Med 1983; 309: 709-713.
17. Department of Health. Report of the Chief Medical Officer's Expert Group on the sleeping position of infants and cot death. London, HMSO, 1993.
18. Orenstein SR, Magill HL, Brooks P. Thickening of feeding for therapy of gastro-esophageai reflux, J Pediatr 1987; 110: 181-185.
19. Vandenplas Y, Sacre-Smits L. Milk thickening agents as a treatment for gastro-esophageal reflux. Clin Pediatr 1987; 26: 66-68.
20. Bailey DJ, Andres JM, Danek GD, Pineiro-Carrero VM. Lack of efficacy of thickened feedings as treatment for gastro-esophageal reflux. J Pediatr 1987; 110: 187-190.
21. Davies AEM, Sandhu BK. Diagnosis and Management of Gastro-esophageal reflux. Arch Dis Child 1995; 73: 82-86.
22. Buts JD, Barndi C, Otte JB. Double-blind controlled study on the efficacy of sodium alginate in reducing gastro-esophageal reflux assessed by 24 hour continuous pH monitoring in infants and children. Eur J Pediatr 1987; 146: 156-158.
23. McHardy G. A multicenter randomized clinical trial of Gaviscon in reflux esophagitis. South Med J 1978; 71: 16-20.
24. Forbes D, Hodgson M, Hill R. The effects of Gaviscon and Metoclopramide in gastro-esophageal reflux in children. J Pediatr Gastroenterol Nutr 1986; 5: 556-559.
25. Oderda G, Dell' olio D, Forni M, Farina L, Tavassoli K, Ansaldi N. Treatment of childhood peptic esophagitis with famotidine or alginate acid. Ital J Gastroenterol 1990; 22: 346-349.
26. Grill BB, Logan LA, Schulz E. Prospective double-blind trial of domperidone (D) versus placebo (Pla) for gastro-oesophageal reflux (GER) in infants and children. Pediatr Res 1989; 25: 114 A.
27. Bines JE, Quinlan JE, Treves S, Kleinman RE, Winter HS. Efficacy of domperidone in infants and children with gastro-esophageal reflux. J Pediatr Gatroenterol Nutr 1992; 14: 400-405.
28. Tack J, Goremans G, Janssens J. A risk-benefit assessment of cisapride in the treatment of gastro-intestinal disorders. Drug Safety 1995; 12: 384-392.
29. Reyntjes AJ, Verlinden M, Aerts T. Development and clinical use of the new gastrointestinal prokinetic drug. Drug Dev Res 1986; 8: 251-261.
30. Cecatelli P. Cisapride restores the decreased lower esophageal sphincter pressure in reflux patients. Gut 1988; 29: 631-635.
31. Corraziar E, Bontempo I, Ansini F. Effect of cisapride on primary peristalsis and lower esophageal sphincter pressure. Gastroenterology 1984; 86: 1054.
32. Brueton MJ, Clarke GS, Sandhu BK. Effect of cisapride on gastro-esophageal reflux in children with and without neurological disorders. Dev Med Child Neurol 1990; 629-632.
33. Brogden RN, carmine AA, Heel RC, Speight TM, Avery GS. Domperidone: A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs 1982; 24: 360-400.
34. Reynthjes AJ, Verlinden M, Aerts T. Development and clinical use of the new gastrointestinal prokinetic drug. Drug Dev Res 1986; 8: 251-261.
35. Albibi R, McCallum RW. Metoclopramide: Pharmacology and clinical application. Ann Intern Med 1983; 98: 86-95.
36. Jacoby HI, Brodie DA. Gastrointestinal actions pf metoclopramide: An experimental study. Gastroenterology 1967; 52: 676-681.
37. Johnson DG, Herbst JJ, Oliveros MA, Stewart DR. Evaluation of gastro-esophageal reflux surgery in children. Pediatrics 1977; 59: 62-68.
38. Machida HM, Forbes DA, Gall DG, Scott RB. Metoclopramide in gastro-esophageal reflux in infancy. J Pediatr 1988; 112: 483-487.
39. Low LCK, Goel KM. Metoclopramide poisoning in children. Arch Dis Child 1980; 55: 310-312.
40. Harrington RA, Hamilton CW, Brogden RN, Linkewich JA, Romankiewicz JA, Heel RS. Metoclopramide: An updated review of its pharmacologic properties and clinical use. Drugs 1983; 25: 451-494.
41. Cucchiara S, Gobio-Casali L, Balli F, Magazzu G, Staiano a, Astolfi R, et al. Cimetidine treatment of reflux esophagitis in children: An Italian multicentric study. J Pediatr Gastroenterol Nutr 1989; 8: 150-156.
42. 2 receptor antagonists have a therapeutic role in childhood? J Pediatr Gastroenterol Nutr 1994; 19: 270-276.
43. Vandenplas Y, Belli D, Benhamou PH, Cadranel S, Cezard JP, Cucchiara S, et al. Current concepts and issues in the management of regurgitation of infants: A re-appraisal. Acta Pediatr 1996; 85: 531-534.
44. Martin PB, Imong SM, Krischer J, Noblett HRN, Sandhu BK. The use of omeprazole for resistant esophagitis in children. Eur J Pediatr Surg 1996; 6: 195-197.
45. Riccobana M, Maurer U, Lackner H, Uray E, Ring E. The role of sonography in the evaluation of gastro-esophageal reflux-correlation of pH metry. Eur J Pediatr 1992; 151: 655-657.
46. Johnson DG. Surgical selection of infants with gastro-esophageal reflux. J Pediatr Surg 1981; 16: 587-594.
47. Cucchiara S, Minella R, lervoline C, Franco MT, Campanozzi A, Franceschi M, et al. Omeprazole and high dose ranitidine in the treatment of refractory reflux esophagitis. Arch Dis Child 1993; 69: 655-659.
48. Gunasekaran TS, Hassal EG. Efficacy and safety of omeprazole for severe gastro-esophageal reflux in children. J Pediatr 1993; 123: 148-154.
49. Nelis GF. Safety profile of omeprazole. Digestion 1989; 44: 68-76.
50. Kato S, Fujii T, Nakano K, Naganuma H, Nakagawa H. The effects of omeprazole on the ultrastructure of gastric parietal cells. J Pediatr Gastroenterol Nutr 1994; 19: 91-96.
51. Spitz L, Roth K, Kiely EM. Operation for gastro-esophageal reflux associated with severe mental retardation. Arch Dis Child 1993; 68: 347-351.
52. Fonkalsrud EW, Ament ME. Gastro-esophageal reflux in childhood. Curr Prob Surg 1996; 33: 3-70.
53. Vandenplas Y. Esophageal pH Monitoring for Gastro-esophageal Reflux in Infants and Children. New York J Wiley, 1992.